At the same time, manufacturing, administration and research & development will be updated with the latest technology. €25 million has been earmarked in the years 2011/2012 primarily for production machinery, and IT, with additional funds for bringing new technologies to market. Optima will profit from the synergies within the group.
During a celebration, Hans Bühler, the managing partner, made reference to a current pharma project which takes advantage of synergies. He said, "A €15 million order, in which our competencies in sterile filling and pharmaceutical freeze drying are combined."